Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Clinical Research Training Program, Duke University School of Medicine 2015 - 2016
  • Fellowship in Electrophysiology, Duke University School of Medicine 2015 - 2016
  • Fellowship in Clinical Research, Duke Clinical Research Institute, Duke University School of Medicine 2013 - 2015
  • Fellowship in Electrophysiology, Medicine, Duke University School of Medicine 2012 - 2013
  • Fellowship in Cardiovascular Medicine, Medicine, Duke University School of Medicine 2010 - 2012
  • Internal Medicine Internship and Residency, Medicine, Duke University School of Medicine 2007 - 2010
  • M.D., University of Florida, College of Medicine 2007
• 

  Duke Appointment History

  • Medical Instructor in the Department of Medicine, Medicine, Cardiology, Medicine 2016 - 2018
• Research
• 

  Selected Grants

  • VIVID awarded by Patient Centered Outcomes Research Institute 2017 - 2020
• 

  External Relationships

  • Covidien (Medtronic)
  • Medtronic (Covidien)
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Chery, Godefroy, Larry Jackson, and Kevin L. Thomas. “Letter to the Editor: Inappropriate subcutaneous implantable cardioverter-defibrillator discharge related to myopotential oversensing.” J Arrhythm 36, no. 5 (October 2020): 948–49. https://doi.org/10.1002/joa3.12415.
       Full Text  Link to Item
    • Jackson, Larry R., Sunghee Kim, Rosalia Blanco, Laine Thomas, Jack Ansell, Gregg C. Fonarow, Bernard J. Gersh, et al. “Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).” Am Heart J 226 (August 2020): 85–93. https://doi.org/10.1016/j.ahj.2020.04.016.
       Full Text  Link to Item
    • Black-Maier, Eric, Benjamin A. Steinberg, Kevin M. Trulock, Frances Wang, Yuliya Lokhnygina, Wanda O’Neal, Sana Al-Khatib, et al. “Effectiveness of catheter ablation of atrial fibrillation according to heart failure etiology.” J Arrhythm 36, no. 1 (February 2020): 84–92. https://doi.org/10.1002/joa3.12291.
       Full Text  Link to Item
    • Sutter, Joanne S., Yuliya Lokhnygina, James P. Daubert, Tristram Bahnson, Kevin Jackson, Jason I. Koontz, Albert Y. Sun, et al. “Safety and efficacy outcomes of left atrial posterior wall isolation compared to pulmonary vein isolation and pulmonary vein isolation with linear ablation for the treatment of persistent atrial fibrillation.” Am Heart J 220 (February 2020): 89–96. https://doi.org/10.1016/j.ahj.2019.11.010.
       Full Text  Link to Item
    • Thomas, Kevin L., Lonnie T. Sullivan, Sana M. Al-Khatib, Nancy Allen LaPointe, Sam Sears, Andrzej S. Kosinski, Larry R. Jackson, Valentina Kutyifa, and Eric D. Peterson. “Videos to reduce racial disparities in ICD therapy Via Innovative Designs (VIVID) trial: Rational, design and methodology.” Am Heart J 220 (February 2020): 59–67. https://doi.org/10.1016/j.ahj.2019.10.011.
       Full Text  Link to Item
    • Wilson, Jimica B., Larry R. Jackson, Francis E. Ugowe, Terrell Jones, George S. A. Yankey, Colin Marts, and Kevin L. Thomas. “Racial and Ethnic Differences in Treatment and Outcomes of Severe Aortic Stenosis: A Review.” Jacc Cardiovasc Interv 13, no. 2 (January 27, 2020): 149–56. https://doi.org/10.1016/j.jcin.2019.08.056.
       Full Text  Open Access Copy  Link to Item
    • Black-Maier, Eric, Alice Parish, Benjamin A. Steinberg, Cynthia L. Green, Zak Loring, Adam S. Barnett, Sana M. Al-Khatib, et al. “Predicting atrial fibrillation recurrence after ablation in patients with heart failure: Validity of the APPLE and CAAP-AF risk scoring systems.” Pacing Clin Electrophysiol 42, no. 11 (November 2019): 1440–47. https://doi.org/10.1111/pace.13805.
       Full Text  Link to Item
    • Sullivan, Lonnie T., Hillary Mulder, Karen Chiswell, Linda K. Shaw, Tracy Y. Wang, Larry R. Jackson, and Kevin L. Thomas. “Racial differences in long-term outcomes among black and white patients with drug-eluting stents.” Am Heart J 214 (August 2019): 46–53. https://doi.org/10.1016/j.ahj.2019.04.005.
       Full Text  Link to Item
    • Linares, Jered D., Larry R. Jackson, Farah Z. Dawood, Katrina Swett, Emelia J. Benjamin, Neil Schneiderman, Elsayed Z. Soliman, et al. “Prevalence of atrial fibrillation and association with clinical, sociocultural, and ancestral correlates among Hispanic/Latinos: The Hispanic Community Health Study/Study of Latinos.” Heart Rhythm 16, no. 5 (May 2019): 686–93. https://doi.org/10.1016/j.hrthm.2018.11.033.
       Full Text  Link to Item
    • Ugowe, Francis E., Larry R. Jackson, and Kevin L. Thomas. “Atrial Fibrillation and Diabetes Mellitus: Can We Modify Stroke Risk Through Glycemic Control?” Circ Arrhythm Electrophysiol 12, no. 5 (May 2019): e007351. https://doi.org/10.1161/CIRCEP.119.007351.
       Full Text  Link to Item
    • Egwim, Chidiebube C., Alvin J. Rucker, Deng C. Madut, Goderfroy S. Chery, Lonnie T. Sullivan, Larry R. Jackson, Wayne B. Batchelor, and Kevin L. Thomas. “Research Participation of a Professional Organization in Clinical Trials: The Association of Black cardiologists Clinical Trial Investigator Identification Project.” J Natl Med Assoc 111, no. 2 (April 2019): 122–33. https://doi.org/10.1016/j.jnma.2018.07.004.
       Full Text  Link to Item
    • Essien, Utibe R., and Larry R. Jackson. “Race Effects in CVD Prediction Models.” J Gen Intern Med 34, no. 4 (April 2019): 484. https://doi.org/10.1007/s11606-018-4789-8.
       Full Text  Link to Item
    • Starks, Monique Anderson, Gillian D. Sanders, Remy Rene Coeytaux, Isaretta L. Riley, Larry R. Jackson, Amanda McBroom Brooks, Kevin L. Thomas, Kingshuk Roy Choudhury, Robert M. Califf, and Adrian F. Hernandez. “Assessing heterogeneity of treatment effect analyses in health-related cluster randomized trials: A systematic review.” Plos One 14, no. 8 (2019): e0219894. https://doi.org/10.1371/journal.pone.0219894.
       Full Text  Link to Item
    • Ugowe, Francis E., and Larry R. Jackson. “Atrial fibrillation and mortality risk: seeing the big picture.” Eur Heart J Qual Care Clin Outcomes 5, no. 1 (January 1, 2019): 6–7. https://doi.org/10.1093/ehjqcco/qcy050.
       Full Text  Link to Item
    • Essien, Utibe R., DaJuanicia N. Holmes, Larry R. Jackson, Gregg C. Fonarow, Kenneth W. Mahaffey, James A. Reiffel, Benjamin A. Steinberg, et al. “Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.” Jama Cardiol 3, no. 12 (December 1, 2018): 1174–82. https://doi.org/10.1001/jamacardio.2018.3945.
       Full Text  Link to Item
    • Jackson, Larry R., Sunghee Kim, Peter Shrader, Rosalia Blanco, Laine Thomas, Michael D. Ezekowitz, Jack Ansell, et al. “Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.” J Thromb Thrombolysis 46, no. 4 (November 2018): 435–39. https://doi.org/10.1007/s11239-018-1715-1.
       Full Text  Link to Item
    • Jackson, Larry R., Kevin L. Thomas, Bronislava Polonsky, Wojciech Zareba, Marc Lahiri, Samir Saba, Scott McNitt, et al. “Effectiveness of high rate and delayed detection ICD programming by race: A MADIT-RIT substudy.” J Cardiovasc Electrophysiol 29, no. 10 (October 2018): 1418–24. https://doi.org/10.1111/jce.13693.
       Full Text  Link to Item
    • Ugowe, Francis E., Larry R. Jackson, and Kevin L. Thomas. “Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.” Heart Rhythm 15, no. 9 (September 2018): 1337–45. https://doi.org/10.1016/j.hrthm.2018.05.019.
       Full Text  Link to Item
    • Jackson, Larry R., Sunghee Kim, Gregg C. Fonarow, James V. Freeman, Bernard J. Gersh, Alan S. Go, Elaine M. Hylek, et al. “Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2-VASc Scores: Findings From the ORBIT-AF I and II Registries.” J Am Heart Assoc 7, no. 16 (August 21, 2018): e008764. https://doi.org/10.1161/JAHA.118.008764.
       Full Text  Open Access Copy  Link to Item
    • Holmqvist, F., B. Rathakrishnan, L. R. Jackson, K. Campbell, and J. P. Daubert. “Pacemaker programming in patients with first-degree AV-block: Programming pattern and possible consequences.” Health Sci Rep 1, no. 6 (June 2018): e39. https://doi.org/10.1002/hsr2.39.
       Full Text  Link to Item
    • Black-Maier, Eric, Xinru Ren, Benjamin A. Steinberg, Cynthia L. Green, Adam S. Barnett, Normita Sta Rosa, Sana M. Al-Khatib, et al. “Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.” Heart Rhythm 15, no. 5 (May 2018): 651–57. https://doi.org/10.1016/j.hrthm.2017.12.001.
       Full Text  Link to Item
    • Al-Shahi Salman, Rustam, Martin S. Dennis, Gordon D. Murray, Karen Innes, Jonathan Drever, Lynn Dinsmore, Carol Williams, et al. “The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.” Trials 19, no. 1 (March 5, 2018): 162. https://doi.org/10.1186/s13063-018-2542-6.
       Full Text  Link to Item
    • Sullivan, Lonnie T., Tiffany Randolph, Peter Merrill, Larry R. Jackson, Chidiebube Egwim, Monique A. Starks, and Kevin L. Thomas. “Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction.” Am Heart J 197 (March 2018): 43–52. https://doi.org/10.1016/j.ahj.2017.10.025.
       Full Text  Link to Item
    • Thomas, Kevin L., Larry R. Jackson, Peter Shrader, Jack Ansell, Gregg C. Fonarow, Bernard Gersh, Peter R. Kowey, et al. “Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).” J Am Heart Assoc 6, no. 12 (December 22, 2017). https://doi.org/10.1161/JAHA.117.006475.
       Full Text  Link to Item
    • Jackson, Larry R., Bharath Rathakrishnan, Kristen Campbell, Kevin L. Thomas, Jonathan P. Piccini, Tristram Bahnson, Jonathan A. Stiber, and James P. Daubert. “Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?” Pacing Clin Electrophysiol 40, no. 4 (April 2017): 442–50. https://doi.org/10.1111/pace.13030.
       Full Text  Link to Item
    • Jackson, Larry R., Eric D. Peterson, Lisa A. McCoy, Christine Ju, Marjorie Zettler, Brian A. Baker, John C. Messenger, et al. “Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.” J Am Heart Assoc 5, no. 10 (October 21, 2016). https://doi.org/10.1161/JAHA.116.003824.
       Full Text  Link to Item
    • Jackson, Larry R., Jonathan P. Piccini, Derek D. Cyr, Matthew T. Roe, Megan L. Neely, Felipe Martinez, Thomas F. Lüscher, et al. “Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.” Clin Cardiol 39, no. 9 (September 2016): 497–506. https://doi.org/10.1002/clc.22562.
       Full Text  Link to Item
    • Sabbag, Avi, Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Michael Glikson, Yitschak Biton, Larry Jackson, Bronislava Polonsky, Wojciech Zareba, and Valentina Kutyifa. “Predictors and Risk of Ventricular Tachyarrhythmias or Death in Black and White Cardiac Patients: A MADIT-CRT Trial Substudy.” Jacc Clin Electrophysiol 2, no. 4 (August 2016): 448–55. https://doi.org/10.1016/j.jacep.2016.03.003.
       Full Text  Link to Item
    • Sullivan, Lonnie T., Larry R. Jackson, and Kevin L. Thomas. “Review of venous thromboembolism and race: the generalizability of treatment guidelines for high-risk populations.” J Thromb Thrombolysis 42, no. 2 (August 2016): 167–71. https://doi.org/10.1007/s11239-016-1352-5.
       Full Text  Link to Item
    • Mentz, Robert J., L Kristin Newby, Ben Neely, Joseph E. Lucas, Sean D. Pokorney, Meena P. Rao, Larry R. Jackson, et al. “Assessment of Administrative Data to Identify Acute Myocardial Infarction in Electronic Health Records.” J Am Coll Cardiol 67, no. 20 (May 24, 2016): 2441–42. https://doi.org/10.1016/j.jacc.2016.03.511.
       Full Text  Link to Item
    • Golwala, Harsh, Larry R. Jackson, DaJuanicia N. Simon, Jonathan P. Piccini, Bernard Gersh, Alan S. Go, Elaine M. Hylek, et al. “Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.” Am Heart J 174 (April 2016): 29–36. https://doi.org/10.1016/j.ahj.2015.10.028.
       Full Text  Link to Item
    • Jackson, Larry R., Sung Hee Kim, Jonathan P. Piccini, Bernard J. Gersh, Gerald V. Naccarelli, James A. Reiffel, James Freeman, et al. “Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.” Clin Cardiol 39, no. 2 (February 2016): 119–25. https://doi.org/10.1002/clc.22504.
       Full Text  Open Access Copy  Link to Item
    • Jackson, Larry R., Christine Ju, Marjorie Zettler, John C. Messenger, David J. Cohen, Gregg W. Stone, Brian A. Baker, Mark Effron, Eric D. Peterson, and Tracy Y. Wang. “Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.” Jacc Cardiovasc Interv 8, no. 14 (December 21, 2015): 1880–89. https://doi.org/10.1016/j.jcin.2015.08.018.
       Full Text  Link to Item
    • Jackson, Larry R., Jonathan P. Piccini, James P. Daubert, Lynne M. Hurwitz Koweek, and Brett D. Atwater. “Localization of pacing and defibrillator leads using standard x-ray views is frequently inaccurate and is not reproducible.” J Interv Card Electrophysiol 43, no. 1 (June 2015): 5–12. https://doi.org/10.1007/s10840-015-9984-5.
       Full Text  Link to Item
    • Jackson, Larry R., Eric D. Peterson, Eze Okeagu, and Kevin Thomas. “Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials.” J Thromb Thrombolysis 39, no. 2 (February 2015): 222–27. https://doi.org/10.1007/s11239-014-1145-7.
       Full Text  Link to Item
    • Jackson, Larry R., Sung Hee Kim, Jonathan P. Piccini, Bernard J. Gersh, Gerald V. Naccarelli, James A. Reiffel, James Freeman, et al. “Sinus Node Dysfunction in Associated With Higher Symptom Burden and Increased Risk of Progression to Permanent Atrial Fibrillation: Results From ORBIT-AF Registry.” Circulation 130 (November 25, 2014).
       Link to Item
    • Jackson, Larry R., and Richard C. Becker. “Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal.” J Thromb Thrombolysis 37, no. 3 (April 2014): 380–91. https://doi.org/10.1007/s11239-013-0958-0.
       Full Text  Link to Item
    • Jackson, Larry R., James P. Daubert, and Kevin L. Thomas. “Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"?” Prog Cardiovasc Dis 54, no. 4 (January 2012): 372–78. https://doi.org/10.1016/j.pcad.2011.11.002.
       Full Text  Link to Item

  • Conference Papers

    • Yankey, George, Zainab Samad, Angie Wu, Karen Chiswell, Larry Jackson, Jimica Wilson, Terrell Jones, and Kevin Thomas. “AORTIC VALVE REPLACEMENT AND OUTCOMES IN PATIENTS WITH SEVERE AORTIC STENOSIS: IS IT BLACK OR WHITE?” In Journal of the American College of Cardiology, 71:A2010–A2010. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)32551-8.
       Full Text
    • Jackson, Larry R., Sunghee Kim, Jack Ansell, Gregg Fonarow, James Freeman, Bernard Gersh, Alan Go, et al. “TREATMENT AND STROKE RISK IN LOW RISK CHA2DS2VASC ATRIAL FIBRILLATION PATIENTS: FINDINGS FROM THE ORBIT-AF REGISTRY.” In Journal of the American College of Cardiology, 67:788–788. Elsevier BV, 2016. https://doi.org/10.1016/s0735-1097(16)30789-6.
       Full Text
    • Golwala, Harsh, Larry Jackson, DaJuanicia Simon, Gregg Fonarow, Paul Chang, Bernard Gersh, Alan Go, et al. “RACIAL/ETHNIC DIFFERENCES IN ATRIAL FIBRILLATION SYMPTOMS, TREATMENT PATTERNS, AND OUTCOMES: INSIGHTS FROM OUTCOMES REGISTRY FOR BETTER INFORMED TREATMENT FOR ATRIAL FIBRILLATION (ORBIT-AF) REGISTRY.” In Journal of the American College of Cardiology, 65:A462–A462. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60462-4.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.